Interleukin-21 (IL-21) Controls Inflammatory Pathways in the Gut

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|7|4|288-291

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.7, Iss.4, 2007-12, pp. : 288-291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting interleukin-21 in inflammatory diseases

By Sarra Massimiliano   Franzèè Eleonora   Pallone Francesco   Monteleone Giovanni  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 6, 2011-06 ,pp. : 695-702

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-25 Negatively Controls Pathogenic Responses in the Gut

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 3, 2011-06 ,pp. : 187-191

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Interleukin-21 in Inflammation and Allergy

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 6, Iss. 1, 2007-03 ,pp. : 63-68

Bentham Science Publishers

Access to resources Recommend Favorite

Interleukin-21 in Immune and Allergic Diseases

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 4, 2012-08 ,pp. : 313-319

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Interleukin-21 in Immune-Mediated Pathologies

By  

Current Drug Targets, Vol. 11, Iss. 5, 2010-05 ,pp. : 645-649

Bentham Science Publishers

Access to resources Recommend Favorite